These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11112116)

  • 21. α1-Proteinase inhibitor (human) in the treatment of hereditary emphysema secondary to α1-antitrypsin deficiency: number and costs of years of life gained.
    Sclar DA; Evans MA; Robison LM; Skaer TL
    Clin Drug Investig; 2012 May; 32(5):353-60. PubMed ID: 22480280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency.
    Tirado-Conde G; Lara B; Miravitlles M
    Ther Adv Respir Dis; 2008 Feb; 2(1):13-21. PubMed ID: 19124355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency.
    Parr DG; Dirksen A; Piitulainen E; Deng C; Wencker M; Stockley RA
    Respir Res; 2009 Aug; 10(1):75. PubMed ID: 19678952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic benefits of recombinant alpha1-antitrypsin IgG1 Fc-fusion protein in experimental emphysema.
    Takeda K; Kim SH; Joetham A; Petrache I; Gelfand EW
    Respir Res; 2021 Jul; 22(1):207. PubMed ID: 34271910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.
    Wewers MD; Casolaro MA; Sellers SE; Swayze SC; McPhaul KM; Wittes JT; Crystal RG
    N Engl J Med; 1987 Apr; 316(17):1055-62. PubMed ID: 3494198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-density lipoproteins potentiate α1-antitrypsin therapy in elastase-induced pulmonary emphysema.
    Moreno JA; Ortega-Gomez A; Rubio-Navarro A; Louedec L; Ho-Tin-Noé B; Caligiuri G; Nicoletti A; Levoye A; Plantier L; Meilhac O
    Am J Respir Cell Mol Biol; 2014 Oct; 51(4):536-49. PubMed ID: 24787644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-1 antitrypsin: now available, but do we need it?
    Russi EW
    Swiss Med Wkly; 2008 Apr; 138(13-14):191-6. PubMed ID: 18389391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of replacement therapy in emphysema caused by alpha 1-antitrypsin deficiency].
    Miravitlles M; Vidal R; Torrella M; Bofill JM; Cotrina M; de Gracia J
    Arch Bronconeumol; 1994 Dec; 30(10):479-84. PubMed ID: 7827760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentation therapy in alpha-1 antitrypsin deficiency.
    Heresi GA; Stoller JK
    Expert Opin Biol Ther; 2008 Apr; 8(4):515-26. PubMed ID: 18352854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches.
    Viglio S; Bak EG; Schouten IGM; Iadarola P; Stolk J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy.
    Dirksen A; Dijkman JH; Madsen F; Stoel B; Hutchison DC; Ulrik CS; Skovgaard LT; Kok-Jensen A; Rudolphus A; Seersholm N; Vrooman HA; Reiber JH; Hansen NC; Heckscher T; Viskum K; Stolk J
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1468-72. PubMed ID: 10556107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pallid mice with genetic emphysema. Neutrophil elastase burden and elastin loss occur without alteration in the bronchoalveolar lavage cell population.
    de Santi MM; Martorana PA; Cavarra E; Lungarella G
    Lab Invest; 1995 Jul; 73(1):40-7. PubMed ID: 7603039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elastin and collagen degradation products in urine of patients with cystic fibrosis.
    Stone PJ; Konstan MW; Berger M; Dorkin HL; Franzblau C; Snider GL
    Am J Respir Crit Care Med; 1995 Jul; 152(1):157-62. PubMed ID: 7599816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications.
    Zuo L; Pannell BK; Zhou T; Chuang CC
    Gene; 2016 Sep; 589(2):118-22. PubMed ID: 26768576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. α
    Bazzan E; Tinè M; Biondini D; Benetti R; Baraldo S; Turato G; Fagiuoli S; Sonzogni A; Rigobello C; Rea F; Calabrese F; Foschino-Barbaro MP; Miranda E; Lomas DA; Saetta M; Cosio MG
    Chest; 2018 Sep; 154(3):607-616. PubMed ID: 29763589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurements of desmosine and isodesmosine by mass spectrometry in COPD.
    Ma S; Lin YY; Turino GM
    Chest; 2007 May; 131(5):1363-71. PubMed ID: 17494786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutrophil recruitment into the lungs is associated with increased lung elastase burden, decreased lung elastin, and emphysema in alpha 1 proteinase inhibitor-deficient mice.
    Cavarra E; Martorana PA; Gambelli F; de Santi M; van Even P; Lungarella G
    Lab Invest; 1996 Aug; 75(2):273-80. PubMed ID: 8765327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. alpha1-Antitrypsin deficiency: best clinical practice.
    Kalsheker NA
    J Clin Pathol; 2009 Oct; 62(10):865-9. PubMed ID: 19783716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled alpha 1-antitrypsin: gauging patient interest in a new treatment.
    Monk R; Graves M; Williams P; Strange C
    COPD; 2013 Aug; 10(4):411-5. PubMed ID: 23537112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.